Home › Childbirth Problems › NCT05763043
Monoferric for Prenatal Iron Deficiency
RecruitingEarly phase 1Healthy volunteers welcome
Who can join
Ages 18 to 65 · Women · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Participants 18 years of age or older between 14 to 42 weeks gestation who are deemed appropriate for IV iron by their treating provider as part of their standard of care treatment. * Iron deficiency anemia, defined as second or third trimester (14 weeks or more) hemoglobin less than or equal to 10.5 g/dL or less than or equal to11 g/dL, respectively, and ferritin less than 50 μg/L * Experience intolerance to oral iron or are greater than 28 weeks gestation * Willing to participate in the study Exclusion Criteria: * Known infectious, inflammatory, or malignant conditions that may confound iron repletion and outcome analysis * Prior IV iron intolerance or hypersensitivity reaction
About the study
A prospective observational study of pregnant women with iron deficiency anemia and oral iron intolerance or advanced gestational age.
What is being tested
- Ferric derisomaltose (drug)
Sponsor: Oregon Health and Science University · Participants: 80 · Started: Jan 18, 2024
Contact the study team
- Women's Health Research Unit Research Unit Department of OB/Gyn · Phone: 503-494-3666
Official record on ClinicalTrials.gov — NCT05763043
Locations in the U.S.
| Oregon | Oregon Health & Science Univerity, Portland |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.